Aim. To study the doctors' opinions on the main aspects of antiplatelet agents use, and to test their knowledge of the basic provisions of the current recommendations on antiplatelet therapy.Material and methods. As a material for the study the results of an anonymous questionnaire in randomly selected doctors were used. The questionnaire contained 11 questions concerning the use of antiplatelet agents for primary and secondary prevention of cardiovascular diseases. 276 questionnaires filled out by 185 therapists, 84 cardiologists and 7 physicians of other therapeutic specialties were analyzed.Results. The results of the study reflect the doctor’s tendency to use acetylsalicylic acid for the primary prevention of cardiovascular diseases, in...
Antiplatelet therapy, mainly consisting of aspirin and P2Y12 receptor antagonists, is the cornersto...
AIMS: Antiplatelet therapy is recommended for the secondary prevention of cardio- and cerebrovascul...
ObjectivesCHARISMA was a landmark randomized clinical trial that failed to demonstrate a benefit of ...
Aim. To study doctors’ knowledge of the clinical guidelines on the use of oral anticoagulants and id...
The role of aspirin and other platelet-active drugs in the treatment and prevention of atherothrombo...
Today, treatment with low doses of acetylsalicylic acid (ASA) (alone or in combination with other an...
Aim: to determine the prevalence of acetylsalicylic acid use as an antiplatelet drug and patient kno...
<p>Aim. To assess the real rate of dual antiplatelet therapy (DAT, acetylsalicylic acid + clopidogre...
The clinical pharmacology of antiplatelet drugs has been reviewed previously by the European Society...
The clinical pharmacology of antiplatelet drugs has been reviewed previously by the European Society...
Item does not contain fulltextRATIONALE, AIMS AND OBJECTIVES: Patients with atherothrombotic cardiov...
of persons worldwide take aspirin on a dailybasis for the prevention and treatment of cardiovas-cula...
Antiplatelet is the most commonly drug used as secondary prevention for Coronary Heart Disease (CHD...
Aim. To assess 5 years trend in level of doctor's adherence to actual guidelines on secondary preven...
Objective: To determine use of class and type of cardioprotective pharmacological agents in patients...
Antiplatelet therapy, mainly consisting of aspirin and P2Y12 receptor antagonists, is the cornersto...
AIMS: Antiplatelet therapy is recommended for the secondary prevention of cardio- and cerebrovascul...
ObjectivesCHARISMA was a landmark randomized clinical trial that failed to demonstrate a benefit of ...
Aim. To study doctors’ knowledge of the clinical guidelines on the use of oral anticoagulants and id...
The role of aspirin and other platelet-active drugs in the treatment and prevention of atherothrombo...
Today, treatment with low doses of acetylsalicylic acid (ASA) (alone or in combination with other an...
Aim: to determine the prevalence of acetylsalicylic acid use as an antiplatelet drug and patient kno...
<p>Aim. To assess the real rate of dual antiplatelet therapy (DAT, acetylsalicylic acid + clopidogre...
The clinical pharmacology of antiplatelet drugs has been reviewed previously by the European Society...
The clinical pharmacology of antiplatelet drugs has been reviewed previously by the European Society...
Item does not contain fulltextRATIONALE, AIMS AND OBJECTIVES: Patients with atherothrombotic cardiov...
of persons worldwide take aspirin on a dailybasis for the prevention and treatment of cardiovas-cula...
Antiplatelet is the most commonly drug used as secondary prevention for Coronary Heart Disease (CHD...
Aim. To assess 5 years trend in level of doctor's adherence to actual guidelines on secondary preven...
Objective: To determine use of class and type of cardioprotective pharmacological agents in patients...
Antiplatelet therapy, mainly consisting of aspirin and P2Y12 receptor antagonists, is the cornersto...
AIMS: Antiplatelet therapy is recommended for the secondary prevention of cardio- and cerebrovascul...
ObjectivesCHARISMA was a landmark randomized clinical trial that failed to demonstrate a benefit of ...